• Tue, September 10, 2024

Sean Dodge Maintained (CDMO) at Buy with Increased Target to $12 on, Sep 10th, 2024

Sean Dodge of RBC Capital, Maintained "Avid Bioservices, Inc." (CDMO) at Buy with Increased Target from $8 to $12 on, Sep 10th, 2024.

Sean, nor any peers, have made any analyst calls on CDMO in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Like: 👍